Être à jour (fr)

Données cartographiées des épidémies

Lisez les dernières nouvelles officielles de l'OMS et du CDC, répertoriées ci-dessous dans la section Flux d'actualités, en commençant par les plus récentes. Voyez les avis des deux organisations cartographiés au niveau mondial immédiatement ci-dessous.**

Skip maps

**Actualisez si la carte ne se charge pas immédiatement. Sachez que toutes les informations n'apparaissent pas sur la carte. Voir également les fils d'actualités ci-dessous.  

Fil d'actualité

Skip Fil d'actualité

Flambées épidémiques de l'OMS

  • Ebola virus disease – Democratic Republic of the Congo ...
    Thu, 02 Apr 2020
    Since 17 February 2020, no new cases have been reported in the ongoing Ebola virus disease (EVD) outbreak in the Democratic Republic of the Congo. While this is a positive development, there is still a high risk of re-emergence of EVD given the current challenges related to limited resources amidst other local and global emergencies, continued insecurity and population displacement in previous hotspots, and limited access to some affected communities. It is therefore critical to maintain surveillance and response operations in the period leading up to the declaration of the end of the outbreak, as well as after the declaration – as outlined in the WHO recommended criteria for declaring the end of the EVD outbreak.

    Ongoing outbreak response efforts continue, which include investigating and validating new alert cases, supporting appropriate care and rapid diagnosis of suspected cases (which continue to be detected), supporting survivors through a multi-disciplinary programme, and strategically transitioning activities. From 24 to 31 March, an average of 4082 alerts were reported and investigated daily. Of these alerts, 274 were validated as suspected cases, requiring specialized care and laboratory testing to rule-out EVD. From 23 to 29 March, 2376 samples were tested including: 1322 blood samples from alive, suspected cases; 365 swabs from community deaths; and 689 samples from re-tested patients. Overall, laboratory activity decreased by 14% compared to the prior week.
  • Ebola virus disease – Democratic Republic of the Congo ...
    Thu, 26 Mar 2020
    No new cases have been reported in the ongoing Ebola virus disease (EVD) outbreak in the Democratic Republic of the Congo since 17 February 2020 (Figure 1).
  • Ebola virus disease – Democratic Republic of the Congo ...
    Thu, 19 Mar 2020
    There have been no new cases of Ebola virus disease (EVD) reported in the ongoing outbreak in the Democratic Republic of the Congo since 17 February 2020. However, because there is still a risk of re-emergence of EVD, it is critical to maintain surveillance and response operations until and after the end of outbreak declaration – as outlined in the WHO recommended criteria for declaring the end of the EVD outbreak.

    Unfortunately, the response faces increasing limitations that could result in delayed detection and control of flare-ups. These limitations include a funding shortfall, ongoing insecurity and lack of access to some areas, and limited staffing and resources amidst other local and global emergencies.

Notices de voyage du CDC:


Cliquez ici pour rechercher des maladies liées aux voyages par nation.

L'assistant clinique de voyage (Travel Clinical Assistant - TCA) est du Département de la santé de la Géorgie.


Rapport hebdomadaire de la morbidité et de la mortalité (MMWR) du CDC:


Mises à jour actuelles du journal

Skip Mises à jour actuelles du journal

Clinical Infectious Diseases Journal

This list includes items from the latest issue of the Clinical Infectious Diseases Journal.

  • A 60-Year-Old Man With Migratory Septic Polyarthritis...
    Tue, 17 Mar 2020
    A 60-year-old man presented with a 2-week history of pain and swelling in both knees, a 1-week history of pain and swelling in the left hand, and a 1-day history of inability to bear weight. His joint pain was associated with fatigue and stiffness, but he did not report having fever, gastrointestinal or genitourinary symptoms, or rash, and he also denied any history of trauma, previous episodes of joint pain, or surgery. He was not taking any relevant medications. He had a history of alcohol abuse with frequent “blackouts” and had had unprotected sex with multiple partners 1 month earlier. He also had a history of homelessness and he had been living in his sister’s basement for the last several months, which was reportedly infested with rodents. He had also consumed home-canned pork and beans 1 month before presentation.
  • News...
    Tue, 17 Mar 2020

  • In the Literature...
    Tue, 17 Mar 2020

Écoute: New England Journal of Medicine

The New England Journal of Medicine is a weekly general medicine journal, and this audio news feed presents interviews with specialists.

Emerging Infectious Diseases Journal:

This list contains articles published online ahead of print.


Center for Infectious Disease Research and Policy:

News from the University of Minnesota Center for Infectious Disease Research and Policy (CIDRAP).

Johns Hopkins Medicine RSS Feed:

Johns Hopkins Medicine science and medical news.

  • Study Shows Increased Risk of Uterine Fibroids in African-America...
    Thu, 28 Dec 2017
    In a study of medical records gathered on hundreds of thousands of African-American women, Johns Hopkins researchers say they have evidence that women with a common form of hair loss have an increased chance of developing uterine leiomyomas, or fibroids.
  • More Tumor Mutations Equals Higher Success Rate With Cancer Immun...
    Wed, 20 Dec 2017

    The “mutational burden,” or the number of mutations present in a tumor’s DNA, is a good predictor of whether that cancer type will respond to a class of cancer immunotherapy drugs known as checkpoint inhibitors, a new study led by Johns Hopkins Kimmel Cancer Center researchers shows. The finding, published in the Dec. 21 New England Journal of Medicine, could be used to guide future clinical trials for these drugs.

  • How Electroconvulsive Therapy Relieves Depression Per Animal Expe...
    Mon, 18 Dec 2017
    In a study using genetically engineered mice, Johns Hopkins researchers have uncovered some new molecular details that appear to explain how electroconvulsive therapy (ECT) rapidly relieves severe depression in mammals, presumably including people. The molecular changes allow more communication between neurons in a specific part of the brain also known to respond to antidepressant drugs.

American Journal of Infection Control:

RSS feed including 'the latest published articles, both published in an issue and published as Articles in Press.'

  • Indwelling medical device use and sepsis risk at a health profes...
    Sepsis is a systemic inflammatory syndrome induced by microbial infection that can result in hypoperfusion and organ dysfunction with subsequent adverse patient outcomes.1 Despite high annual expenditures for medical intervention2,3 and advances in acute care management,4 mortality among hospitalized sepsis patients continues to be a major clinical outcome.5,6 Prior studies have focused on prevention and early recognition of sepsis by identifying risk factors for the development of sepsis of any severity.
  • How much is adequate staffing for infection control? A determini...
    Recommended staffing of infection preventionists (IP) has varied over time and settings. In 1985, 1 IP was recommended for every 250 occupied beds in acute care facilities.1,2 This was subsequently revised to 1 IP full time equivalent (FTE) for the first 100 occupied beds and 1 IP FTE for every additional 250 beds by the National Nosocomial Infections Surveillance, CDC in 1999.3 A Delphi project in 2002 suggested a ratio of 0.8 to 1.0 IP for every 100 occupied acute care beds.4 The Public Health Agency of Canada recommended 1 IP per 100 beds in areas of higher acuity and 1 IP per 133 beds in areas of lesser acuity in hospitals.
  • The importance of designing and implementing participatory surve...
    The atypical pneumonia case, caused by a novel coronavirus (2019-nCoV), was reported by the World Health Organization,1 which has been spreading at high rates since the end of December 2019.2,3 The 2019-nCoV case was first detected and confirmed in Wuhan, China, before being identified in other Chinese cities. It has also been reported in most countries of the world.4,5 On January 30, 2020, the World Health Organization declared the outbreak as a Public Health Emergency of International Concern.